GRANT PICKERING - 02 Sep 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
02 Sep 2025
Net transactions value
-$342,110
Form type
4
Filing time
04 Sep 2025, 16:09:58 UTC
Previous filing
03 Jun 2025
Next filing
10 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PICKERING GRANT CHIEF EXECUTIVE OFFICER, Director C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact 04 Sep 2025 0001258693

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability $90,167 -2,857 -0.55% $31.56 516,247 02 Sep 2025 Direct F1, F2
transaction PCVX Common Stock Tax liability $144,008 -4,563 -0.88% $31.56 511,684 02 Sep 2025 Direct F1
transaction PCVX Common Stock Tax liability $107,935 -3,420 -0.67% $31.56 508,264 02 Sep 2025 Direct F1
holding PCVX Common Stock 136,215 02 Sep 2025 By Children's Trust F3
holding PCVX Common Stock 136,215 02 Sep 2025 By Children's Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
F2 Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025.
F3 Shares are held directly by a trust for the benefit of the Reporting Person's son.
F4 Shares are held directly by a trust for the benefit of the Reporting Person's daughter.